6533b7d9fe1ef96bd126b93b

RESEARCH PRODUCT

Versatile synthesis of cationic N-heterocyclic carbene–gold(i) complexes containing a second ancillary ligand. Design of heterobimetallic ruthenium–gold anticancer agents

María ContelBenelita T. ElieJacob Fernández-gallardoMercedes Sanaú

subject

Stereochemistrychemistry.chemical_elementLigands010402 general chemistry01 natural sciencesArticleRutheniumCatalysisCatalysischemistry.chemical_compoundHeterocyclic CompoundsCationsMaterials Chemistry010405 organic chemistryChemistryLigandSecond ancillaryMetals and AlloysCationic polymerizationGeneral ChemistryCombinatorial chemistry0104 chemical sciencesSurfaces Coatings and FilmsElectronic Optical and Magnetic MaterialsRutheniumCeramics and CompositesGoldMethaneCarbene

description

We describe a versatile and quick route to cationic gold(i) complexes containing N-heterocyclic carbenes and a second ancillary ligand (such as phosphanes, phosphites, arsines and amines) of interest for the synthesis of compounds with potential catalytic and medicinal applications. The general synthetic strategy has been applied in the preparation of novel cationic heterobimetallic ruthenium(ii)-gold(i) complexes that are highly cytotoxic to renal cancer Caki-1 and colon cancer HCT 116 cell lines while showing a synergistic effect and being more selective than their monometallic counterparts.

https://doi.org/10.1039/c5cc09718e